Resource Center
Resource Center
New agreements with DeepTek and Delft Imaging cut annual software costs by up to 65 percent.
Read more
This is the current list of sessions with CHAI participation at AIDS 2026, which will take place virtually and in-person in Rio de Janeiro, Brazil from July 26 to 31, 2026.
Read more
CHAI, the Agency Fund, and Endless Network have launched the AI Commons for Global Health to ensure AI tools work for health systems in low- and middle-income countries.
Read more
CHAI is pleased to release the 2026 Hepatitis C Treatment Market Memo, the latest in our series of hepatitis C market intelligence publications. A decade ago, curing hepatitis C cost more than US$84,000 per patient. Today, the same cure can be procured at around US$60 per patient. Few global health markets have changed so dramatically....
Read more
Updated analysis from CHAI tracks the state of African vaccine manufacturing ambitions in 2026 Africa has long relied on other parts of the world for its vaccines, a vulnerability COVID-19 made impossible to ignore. That crisis galvanized African leaders and international partners to act, prompting the creation of the Partnerships for African Vaccine Manufacturing (PAVM)...
Read more
New CHAI data from 2025 into early 2026: HIV testing, treatment, and prevention have shown little recovery from global funding cuts. Read the June 2026 memo.
Read more
Regional vaccine manufacturing in Southeast Asia has made significant progress but market risks remain. New CHAI and RVMC research maps these risks and sets out what needs to change.
Read more
Regional vaccine manufacturing in Latin America is growing but is it sustainable? New CHAI and RVMC research identifies the gaps and what it takes to close them.
Read more
How is lenacapavir PrEP rolling out globally? CHAI and WIts RHI track progress in early adopter countries and the path to generic market entry.
Read more
The ONE Campaign and CHAI announced a strategic partnership to drive health financing reform across Africa.
Read more